Ewelina Gumbarewicz

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Transforming Growth Factor

Histone Deacetylase

Metabolic Syndrome

Top Venues

International journal of molecular sciences

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Pawlicka, Ewelina Gumbarewicz, Ewa Blaszczak, Andrzej Stepulak
Transcription Factors and Markers Related to Epithelial-Mesenchymal Transition and Their Role in Resistance to Therapies in Head and Neck Cancers. Cancers 16 (7) (2024)
Marta Pawlicka, Ewelina Gumbarewicz, Ewa Blaszczak, Andrzej Stepulak
Transcription Factors and Markers Related to Epithelial-Mesenchymal Transition and Their Role in Resistance to Therapies in Head and Neck Cancers. Cancers 16 (7) (2024)
Marta Pawlicka, Ewelina Gumbarewicz, Ewa Blaszczak, Andrzej Stepulak
Transcription Factors and Markers Related to Epithelial-Mesenchymal Transition and Their Role in Resistance to Therapies in Head and Neck Cancers. Cancers 16 (7) (2024)
Ewelina Gumbarewicz, Agata Jarząb, Andrzej Stepulak, Wirginia Kukuła-Koch
Zingiber officinale Rosc. in the Treatment of Metabolic Syndrome Disorders-A Review of In Vivo Studies. International journal of molecular sciences 23 (24) (2022)
Ewelina Gumbarewicz, Agata Jarząb, Andrzej Stepulak, Wirginia Kukuła-Koch
Zingiber officinale Rosc. in the Treatment of Metabolic Syndrome Disorders-A Review of In Vivo Studies. International journal of molecular sciences 23 (24) (2022)
Ewelina Gumbarewicz, Agata Jarząb, Andrzej Stepulak, Wirginia Kukuła-Koch
Zingiber officinale Rosc. in the Treatment of Metabolic Syndrome Disorders-A Review of In Vivo Studies. International journal of molecular sciences 23 (24) (2022)
Anna Wawruszak, Ewelina Gumbarewicz, Estera Okoń, Witold Jeleniewicz, Jakub Czapiński, Marta Halasa, Karolina Okła, Jolanta Smok-Kalwat, Artur Bocian, Adolfo Rivero-Muller, Andrzej Stepulak
Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties. Cancer management and research 11 (2019)